Your search returned 110 studies. (Get alerts for new studies):
- Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
Conditions: Neurotoxicity - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- E7389 and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
7 Locations available
- L-Arginine Supplements in Treating Women Who Are Cancer Survivors
Conditions: Cancer Survivor - Sexual Dysfunction and Infertility - Sexuality and Reproductive Issues - Unspecified Adult Solid Tumor, Protocol Specific
25 Locations available
- Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Conditions: Kidney Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
271 Locations available
- Collecting and Storing Tissue and Fluid Samples From Patients Receiving Standard Care at the National Cancer Institute
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of Blood and/or Urine Samples From Cancer Patients Receiving Radiation Therapy at the National Cancer Institute
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Conditions: Nausea and Vomiting - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- LMP400 and LMP776 in Treating Patients With Relapsed Solid Tumors or Lymphomas
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol S
1 Location available
- Screening Study of Patient Eligibility for Participation in National Cancer Institute Radiation Therapy Clinical Trials
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers
Conditions: Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Promoting Physical Activity In After-School Programs for Urban Adolescents
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or
Conditions: Breast Cancer - Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
Conditions: Kidney Cancer - Lung Cancer - Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Conditions: Nausea and Vomiting - Unspecified Adult Solid Tumor, Protocol Specific
4 Locations available
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
387 Locations available
- Studying Radiation Doses in Patients Undergoing Stem Cell Transplant Treated With Total-Body Irradiation
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
2 Locations available
- Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Everolimus and Gemcitabine Hydrochloride in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- High-Dose or Low-Dose Vorinostat in Combination With Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor - Protocol Specific - Breast Cancer - Female
1 Location available
- ABC294640 in Treating Patients With Advanced Solid Tumors
Conditions: Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For
Conditions: Nausea and Vomiting - Unspecified Adult Solid Tumor, Protocol Specific
9 Locations available
- An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physi
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
Conditions: Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
4 Locations available
- Advanced Care Planning Using the Five Wishes Document in Young Patients With Metastatic, Recurrent, or Progressive Cancer or HIV Disease
Conditions: Psychosocial Effects of Cancer and Its Treatment - Transitional Care Planning - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
2 Locations available
- Assessment Tool for Older Patients With Cancer
Conditions: Cognitive/Functional Effects - Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
8 Locations available
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Computer Program to Find and Diagnose Cancer or Other Diseases Using Radiologic Images
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- AT13387 in Treating Patients With Refractory Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer - Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Nonneoplastic Condition - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Bevacizumab and Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin in Treating Patients With Refractory Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Veliparib and Dinaciclib With or Without Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors or Prostate or Kidney Cancer
Conditions: Kidney Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Irinotecan and ABT-888 in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Electromagnetic Device Tracking in Patients Undergoing CT-Guided Biopsy or Ablation
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia
Conditions: Leukemia - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- MEK Inhibitor AZD6244 and Cetuximab Treating Patients With Advanced or Refractory Solid Tumors That Cannot Be Removed By Surgery
Conditions: Colorectal Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
Conditions: Cutaneous Melanoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
Conditions: Malignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of Patient Eligibility for Participation in Surgery Clinical Trials
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
17 Locations available
- Neuropsychological Measures in Patients Undergoing Radiation Therapy for Brain Metastases
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis
Conditions: Metastatic Cancer - Pain - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- ABT-888 in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Pancreatic Cancer - Peritoneal Cavity Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Pr
1 Location available
- Tissue Sample Collection From Patients With Fanconi Anemia
Conditions: Fanconi Anemia - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
Conditions: Fatigue - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Breast Cancer - Colorectal Cancer - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Evaluation of Food Effect on Pharmacokinetics of GDC-0449
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Gene Changes and Risk Factors in Nuclear Workers in Mayak, Russia
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases
Conditions: Bone Metastases - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN™ in Subjects With Cancer Who Also Have Impaired Renal Function
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
7 Locations available
- Late Effects of Radiation Therapy and Natural History of Disease in Patients Previously Treated for Cancer at the National Institutes of Health
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Breast Imaging Using Indium In 111 CHX-A DTPA Trastuzumab in Patients With Primary Cancer or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Assessing Response to Treatment in Patients With Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors
Conditions: Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- ABT-888 With or Without Mitomycin in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
Conditions: Hypertension - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Solid Tumor
1 Location available
- Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
Conditions: Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor
1 Location available
- PXD101 and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
5 Locations available
- Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Conditions: Dermatologic Complications - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
4 Locations available
- Studying Biomarkers in Detecting Heart Damage in Patients Receiving Chemotherapy
Conditions: Cardiac Toxicity - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Biomarkers of RO4929097and Other Drugs in Treating Patients With Metastatic or Unresectable Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- CBLB502 in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Conditions: Leukemia - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Kidney Cancer - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors or Progressive or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
5 Locations available
- Studying Patients With a Personal or Family History of Cancer Caused by a Virus
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Sarcoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Conditions: Breast Cancer - Cardiovascular Complications - Colorectal Cancer - Fallopian Tube Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Precancerous Condition - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Neurotoxicity - Radiation Toxicity - Unspecified Adult Solid Tumor, Protocol Specific
10 Locations available
- Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
|